Viral News
March 31, 2023 – An antiviral therapy in early development has the potential to prevent COVID-19 infections when given as a nasal spray as little as 4 hours before exposure. It also appears to work as a treatment if used within 4 hours after infection inside the nose, new research reveals. Known as TriSb92 (brand name …
Continue reading “Nasal COVID Treatment Shows Early Promise Against Multiple Variants”
March 28, 2023 – Over and over, Mesha Liely was told that it was all in her head. That she was just a woman prone to exaggeration. That she had anxiety. That she simply needed to get more rest and take better care of herself. The first time an ambulance rushed her to the emergency room …
Continue reading “Bias, Lack of Access Make Long COVID Worse for Patients of Color”
March 23, 2023 — This month, I took care of a patient who recently contracted COVID-19 and was complaining of chest pain. After ruling out the possibility of a heart attack, pulmonary embolism, or pneumonia, I concluded that this was a residual symptom of COVID. Chest pain is a common lingering symptom of COVID. However, …
Continue reading “Long COVID Mystery Has Doctors in the Dark”
NOVIDS is the term some use to describe those who haven’t gotten COVID. But researchers are not overly fond of the word. They’re looking for the possible genetic underpinnings to a group of people they prefer to call “resisters.” Source: https://www.webmd.com/covid/news/20230316/do-some-have-genes-to-dodge-covid?src=RSS_PUBLIC
With the third anniversary of COVID upon us, various experts give us their takes on the future of COVID-19 and how their perspectives have changed over 3 years. Source: https://www.webmd.com/special-reports/covid-3-years/20230315/qa-the-future-of-covid-19?src=RSS_PUBLIC
Our current poll found that almost a third – 30% – of our audience thinks the pandemic has already come to an end, up from 16% a year ago. Source: https://www.webmd.com/special-reports/covid-3-years/20230315/webmd-covid-poll?src=RSS_PUBLIC
More than 3 years into the pandemic, finding out how many Americans have long COVID – and what to about it – has proved to be far harder than identifying those infected with the virus who have recovered or died from it. Source: https://www.webmd.com/special-reports/covid-3-years/20230315/extent-long-covid?src=RSS_PUBLIC
SOURCES David L. Hoey, president and CEO of Vaxxas, Cambridge, MA, and Brisbane, Australia. Pablo Penaloza-MacMaster, PhD, assistant professor of microbiology and immunology, Feinberg School of Medicine, Northwestern University, Chicago. Jasdave Chahal, PhD, co-founder and chief scientist, Tiba Biotech, Cambridge, MA, and Brisbane, Australia. Vaxart news release: “Vaxart Announced Positive Top-line Phase II clinical Study …
Continue reading “Future COVID Vaccines Must Be Better; Science Races to Respond”
March 15, 2023 – Three years after COVID-19 rocked the world, the pandemic has evolved into a steady state of commonplace infections, less frequent hospitalization and death, and continued anxiety and isolation for older people and those with weakened immune systems. After about 2½ years of requiring masks in health care settings, the CDC lifted …
March 13, 2023 – Last year, federal officials warned of a likely COVID-19 surge this winter. It never happened, making this the first pandemic winter without a significant spike. Deaths from COVID-19 and official case counts declined dramatically, compared to the surges seen during the winter of 2021-2022. Many experts have said that wave never …
The debate over the origins of the COVID-19 virus has overwhelmingly come down partisan lines. Democrats tend to believe it came out of a wet market in Wuhan, China. Republicans tend to support the theory that it came from a leak at the Wuhan Institute of Virology. It’s easy to see why partisans have come …
March 10, 2023 – Health care workers infected with the COVID-19 Omicron variant were far less likely to experience significant long COVID symptoms than those who contracted the original SARS-CoV-2 virus, according to new research out of Switzerland. The results, which will be presented at the European Congress of Clinical Microbiology & Infectious Diseases conference in …
Continue reading “Omicron Much Less Likely to Cause Long COVID, Study Finds”
